Babaodan inhibits cell proliferation and metastasis and enhances anti-tumor effects of camrelizumab by inhibiting M2 phenotype macrophages in hepatocellular carcinoma
Bibliographic Data
Biology · Cancer · Carcinoma · Cell culture · Cell growth · Gene · Hepatocellular carcinoma · Metastasis · Pathology · Phenotype · Tumor cells · Cancer, Stress, Anesthesia, and Immune Response · Immune cells in cancer · Medicine · Nanoplatforms for cancer theranostics · Biochemistry · Cancer Research · Immunology · Internal Medicine
Babaodan ameliorates metabolic dysfunction-associated steatotic liver disease with co-modulation of FXR, NF-κB, and SLC22A7 in bile acid metabolism
Babaodan alleviates MAFLD through hepatic glycerophospholipid metabolism and PPARγ/RXRA/GPAT3 based on spatial metabolomics and proteomics analysis
Babaodan suppresses inflammatory and vascular microenvironment in triple-negative breast cancer by inhibiting the cGAS-STING/NF-κB signaling pathway
| Citations per year | 3 |
|---|---|
| Citation span | 2026 - 2027 (2) |
| Highly cited | No |